JAIME LEANDRO FOUNDATION FOR THERAPEUTIC CANCER VACCINES (EIN 853117614) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2020

Legal Domicile

Principal Officer

WILLIAM HOOS

Phone

6787937360

Tax Period

2024-01-01 to 2024-12-31

JAIME LEANDRO FOUNDATION FOR THERAPEUTIC CANCER VACCINES, founded in 2020, is a community nonprofit in the Diseases & Disorders sector that reported $4.8M in total revenue in fiscal year 2024. Revenue surged 91% from the prior year, signaling strong growth momentum. The organization ran a surplus of $2.4M, a strong 50% operating margin.

Mission

THE IMPROVEMENT OF ACCESS TO AND DATA ABOUT THERAPEUTIC NEOANTIGEN CANCER VACCINES

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,330,164

Program Service Revenue $2,426,748

Investment Income $932

Other Revenue $0

TOTAL REVENUE $4,757,844

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $2,357,624

Other Expenses $2,357,624

TOTAL EXPENSES $2,357,624

Year-over-Year Comparison

	2024	2023	Change
Revenue	$4,757,844	$2,489,623	+0.9%
Expenses	$2,357,624	$2,330,695	+0.0%
Net Income	$2,400,220	$158,928	+14.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$30,000

Total Directors

$42,400

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
WILLIAM HOOS	PRESIDENT	8.00	Officer Director	$30,000	$0	$30,000
MALACHI GRIFFITH	BOARD MEMBER	0.50	Director	$12,400	$0	$12,400
JASON CHANG	TREASURER	1.00	Director	$0	$0	$0
WILLIAM GILLANDERS	BOARD MEMBER	0.50	Director	$0	$0	$0
ANDREW JACOBS	SECRETARY	1.00	Director	$0	$0	$0
J MARTIN TENENBAUM	BOARD MEMBER	0.50	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$4,757,844	$2,357,624	$2,980,237	$2,400,220
2023	$2,489,623	$2,330,695	$937,662	$158,928
2022	$1,344,079	$1,279,455	$546,360	$64,624
2021	$335,642	$416,192	$277,944	$-80,550

JAIME LEANDRO FOUNDATION FOR THERAPEUTIC CANCER VACCINES